Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.255
-0.105 (-3.12%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 7.38 | 0.23 | 0.35 | 1.24 | 2.74 | Upgrade
|
| Cash & Short-Term Investments | 7.38 | 0.23 | 0.35 | 1.24 | 2.74 | Upgrade
|
| Cash Growth | 3121.83% | -33.62% | -72.18% | -54.81% | 98.98% | Upgrade
|
| Other Receivables | 0.23 | 0.07 | 0.01 | 0.03 | 0.05 | Upgrade
|
| Receivables | 0.23 | 0.07 | 0.01 | 0.03 | 0.05 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.18 | 0.01 | 0.45 | 0.33 | Upgrade
|
| Total Current Assets | 7.62 | 0.48 | 0.36 | 1.72 | 3.12 | Upgrade
|
| Total Assets | 7.62 | 0.48 | 0.36 | 1.72 | 3.12 | Upgrade
|
| Accounts Payable | 0.27 | 0.25 | 0.35 | 0.21 | 0.31 | Upgrade
|
| Accrued Expenses | 1.41 | 1.13 | 0.52 | 0.42 | 0.2 | Upgrade
|
| Short-Term Debt | 1.2 | 0.57 | 0.21 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 4.37 | - | 6.47 | - | Upgrade
|
| Current Unearned Revenue | - | - | 2.05 | 1.98 | 2.21 | Upgrade
|
| Other Current Liabilities | - | 0.16 | 0 | 0 | 0 | Upgrade
|
| Total Current Liabilities | 2.87 | 6.49 | 3.14 | 9.08 | 2.72 | Upgrade
|
| Long-Term Debt | - | - | 7.41 | - | 6.08 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.62 | 0.69 | 0.79 | Upgrade
|
| Total Liabilities | 2.87 | 6.49 | 11.17 | 9.77 | 9.58 | Upgrade
|
| Additional Paid-In Capital | 60.54 | 1.04 | 1.04 | 0.75 | 0.75 | Upgrade
|
| Retained Earnings | -55.79 | -42.15 | -46.95 | -42.82 | -41.23 | Upgrade
|
| Total Common Equity | 4.74 | -41.1 | -45.91 | -42.06 | -40.48 | Upgrade
|
| Shareholders' Equity | 4.74 | -6.01 | -10.81 | -8.05 | -6.47 | Upgrade
|
| Total Liabilities & Equity | 7.62 | 0.48 | 0.36 | 1.72 | 3.12 | Upgrade
|
| Total Debt | 1.2 | 4.95 | 7.62 | 6.47 | 6.08 | Upgrade
|
| Net Cash (Debt) | 6.18 | -4.72 | -7.27 | -5.23 | -3.33 | Upgrade
|
| Net Cash Per Share | 10.91 | -29.08 | -41.90 | -32.26 | -20.54 | Upgrade
|
| Filing Date Shares Outstanding | 5.18 | 0.16 | 3.93 | 0.16 | 0.16 | Upgrade
|
| Total Common Shares Outstanding | 5.18 | 0.16 | 0.16 | 0.16 | 0.16 | Upgrade
|
| Working Capital | 4.74 | -6.01 | -2.78 | -7.36 | 0.39 | Upgrade
|
| Book Value Per Share | 0.92 | -253.42 | -283.02 | -259.32 | -249.57 | Upgrade
|
| Tangible Book Value | 4.74 | -41.1 | -45.91 | -42.06 | -40.48 | Upgrade
|
| Tangible Book Value Per Share | 0.92 | -253.42 | -283.02 | -259.32 | -249.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.